Wang W, McKinnie SM, Farhan M, Paul M, McDonald T, McLean B, Llorens-Cortes C, Hazra S, Murray AG, Vederas JC, Oudit GY (May 2016). "Angiotensin Converting Enzyme 2 Metabolizes and Partially Inactivates Pyrapelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System". Hypertension68: 365–77. PMID27217402. doi:10.1161/HYPERTENSIONAHA.115.06892.
Bünning P, Riordan JF (Jul 1985). "The functional role of zinc in angiotensin converting enzyme: implications for the enzyme mechanism". Journal of Inorganic Biochemistry24 (3): 183–98. PMID2995578. doi:10.1016/0162-0134(85)85002-9.
Zhang C, Wu S, Xu D (Jun 2013). "Catalytic mechanism of angiotensin-converting enzyme and effects of the chloride ion". The Journal of Physical Chemistry B117 (22): 6635–45. PMID23672666. doi:10.1021/jp400974n.
Bünning P (1983). "The catalytic mechanism of angiotensin converting enzyme". Clinical and Experimental Hypertension. Part A, Theory and Practice5 (7-8): 1263–75. PMID6315268. doi:10.3109/10641968309048856.
Wang P, Fedoruk MN, Rupert JL (2008). "Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?". Sports Medicine38 (12): 1065–79. PMID19026021. doi:10.2165/00007256-200838120-00008.
Wang W, McKinnie SM, Farhan M, Paul M, McDonald T, McLean B, Llorens-Cortes C, Hazra S, Murray AG, Vederas JC, Oudit GY (May 2016). "Angiotensin Converting Enzyme 2 Metabolizes and Partially Inactivates Pyrapelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System". Hypertension68: 365–77. PMID27217402. doi:10.1161/HYPERTENSIONAHA.115.06892.
Bünning P, Riordan JF (Jul 1985). "The functional role of zinc in angiotensin converting enzyme: implications for the enzyme mechanism". Journal of Inorganic Biochemistry24 (3): 183–98. PMID2995578. doi:10.1016/0162-0134(85)85002-9.
Zhang C, Wu S, Xu D (Jun 2013). "Catalytic mechanism of angiotensin-converting enzyme and effects of the chloride ion". The Journal of Physical Chemistry B117 (22): 6635–45. PMID23672666. doi:10.1021/jp400974n.
Bünning P (1983). "The catalytic mechanism of angiotensin converting enzyme". Clinical and Experimental Hypertension. Part A, Theory and Practice5 (7-8): 1263–75. PMID6315268. doi:10.3109/10641968309048856.
Wang P, Fedoruk MN, Rupert JL (2008). "Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?". Sports Medicine38 (12): 1065–79. PMID19026021. doi:10.2165/00007256-200838120-00008.